During the past decade, University Hospital, Kyoto Prefectural University of Medicine conducted 75 clinical trials. In the 10-year time frame, 75 clinical trials started and 26 clinical trials were completed, i.e. on average, 34.7% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 17 clinical trials were completed. i.e. 38.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital, Kyoto Prefectural University of Medicine" #1 sponsor was "Celgene" with 11 trials, followed by "Pfizer" with 11 trials sponsored, "Janssen Research & Development, LLC" with 10 trials sponsored, "Amgen" with 6 trials sponsored and "Eli Lilly and Company" with 6 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital, Kyoto Prefectural University of Medicine" #1 collaborator was "Gilead Sciences" with 4 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital, Kyoto Prefectural University of Medicine" are "Multiple Myeloma" (14 trials), "Crohn's Disease" (5 trials), "Ulcerative Colitis" (5 trials), "Nonalcoholic Steatohepatitis" (4 trials) and "Psoriasis" (4 trials). Many other conditions were trialed in "University Hospital, Kyoto Prefectural University of Medicine" in a lesser frequency.

Most popular intervention types in "University Hospital, Kyoto Prefectural University of Medicine" are "Drug" (82 trials), "Biological" (4 trials), "Device" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (28 trials), "Dexamethasone" (10 trials), "Lenalidomide" (8 trials), "Rituximab" (8 trials) and "Bortezomib" (7 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital, Kyoto Prefectural University of Medicine" are 84 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are 50 active trials in "University Hospital, Kyoto Prefectural University of Medicine". 1 are not yet recruiting, 23 are recruiting, 25 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 34 completed trials in University Hospital, Kyoto Prefectural University of Medicine, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital, Kyoto Prefectural University of Medicine, 6 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".